Name | CATPB |
---|---|
Synonyms |
(3S)-3-{(Z)-[2-(3-Chlorophenyl)-1-hydroxyethylidene]amino}-4-[4-(trifluoromethyl)phenyl]butanoic acid
(S)-3-(2-(3-Chlorophenyl)acetamido)-4-(4-(trifluoromethyl)phenyl)butanoic acid CATPB Benzenebutanoic acid, β-[[(1Z)-2-(3-chlorophenyl)-1-hydroxyethylidene]amino]-4-(trifluoromethyl)-, (βS)- |
Description | CATPB is a potent, selective free fatty acid receptor 2 (FFA2R/GPR43) antagonist[1]. |
---|---|
Related Catalog | |
Target |
FFA2R(GPR43)[1] |
In Vitro | CATPB inhibits the transient rise in intracellular Ca2+ induced in neutrophils by acetate or Cmp1 (FFAR2 agonist)[1]. CATPB inhibits Cmp1-induced NADPH oxidase activity[1]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 531.4±60.0 °C at 760 mmHg |
Molecular Formula | C19H17ClF3NO3 |
Molecular Weight | 399.79 |
Flash Point | 275.2±32.9 °C |
Exact Mass | 399.084900 |
LogP | 4.92 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.546 |